InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 18.69
-0.81 (-4.15%)
At close: Jun 1, 2026
InventisBio Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -303.73 | -316.87 | -240.2 | -283.98 | -483.49 | -357.91 |
Depreciation & Amortization | 13.87 | 13.87 | 18.94 | 17.33 | 15.61 | 11.1 |
Other Amortization | 2.33 | 2.33 | 1.05 | 4.88 | 4.31 | 3.79 |
Loss (Gain) From Sale of Assets | - | - | -0.08 | - | - | - |
Loss (Gain) From Sale of Investments | -3.39 | -3.39 | -1.3 | -6.56 | - | - |
Stock-Based Compensation | - | - | - | - | - | 33.4 |
Provision & Write-off of Bad Debts | 12.6 | 12.6 | 8.88 | 9.29 | - | - |
Other Operating Activities | -106.16 | -12.42 | -22.8 | -3.91 | -20.93 | 12.33 |
Change in Accounts Receivable | 58.69 | 58.69 | 13.96 | -164.16 | -32.68 | -0.96 |
Change in Accounts Payable | 53.78 | 53.78 | -67.87 | 50.49 | 9.45 | 46.19 |
Change in Other Net Operating Assets | 35.73 | 35.73 | 47.45 | 68.86 | 30.84 | -0 |
Operating Cash Flow | -236.05 | -155.44 | -241.97 | -307.75 | -476.89 | -252.07 |
Capital Expenditures | -6.18 | -6.92 | -7.56 | -6.29 | -7.69 | -26.52 |
Investment in Securities | 36.58 | -35.97 | -67.52 | -700 | - | - |
Other Investing Activities | 21.45 | 16.56 | 21.15 | 6.95 | - | - |
Investing Cash Flow | 51.86 | -26.33 | -53.93 | -699.33 | -7.69 | -26.52 |
Long-Term Debt Issued | - | - | - | 16.29 | - | - |
Total Debt Issued | - | - | - | 16.29 | - | - |
Long-Term Debt Repaid | - | - | - | -16.29 | -12.92 | -9.23 |
Total Debt Repaid | - | - | - | -16.29 | -12.92 | -9.23 |
Net Debt Issued (Repaid) | - | - | - | - | -12.92 | -9.23 |
Issuance of Common Stock | 0.09 | 6.97 | 7.59 | - | 2,000 | - |
Other Financing Activities | -24.99 | -13.19 | -14.07 | -13.57 | -13.09 | -6.69 |
Financing Cash Flow | -24.9 | -6.22 | -6.48 | -13.57 | 1,974 | -15.91 |
Foreign Exchange Rate Adjustments | -3.39 | -2.83 | 0.5 | 1.27 | 21.95 | -13.18 |
Net Cash Flow | -212.48 | -190.83 | -301.88 | -1,019 | 1,511 | -307.68 |
Free Cash Flow | -242.22 | -162.36 | -249.53 | -314.04 | -484.59 | -278.59 |
Free Cash Flow Margin | -338.10% | -435.41% | -147.84% | -169.27% | - | - |
Free Cash Flow Per Share | -0.42 | -0.28 | -0.44 | -0.55 | -0.95 | -0.61 |
Cash Interest Paid | - | - | - | 0.18 | - | - |
Cash Income Tax Paid | 0.08 | 0.09 | -8.02 | -27.06 | -7.82 | -10.22 |
Levered Free Cash Flow | -138.17 | -49.3 | -163.01 | -245.48 | -286.5 | -173.17 |
Unlevered Free Cash Flow | -137.71 | -48.78 | -162.59 | -244.96 | -285.85 | -172.43 |
Change in Working Capital | 148.44 | 148.44 | -6.46 | -44.81 | 7.6 | 45.23 |